Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18662443 | REGENERATIVE POLYPEPTIDES AND USES THEREOF | May 2024 | February 2025 | Allow | 9 | 2 | 0 | Yes | No |
| 18596638 | PROTEOMICS REACTOR, PROTEIN CHROMATOGRAPHIC SEPARATION PLATFORM AND USE THEREOF | March 2024 | September 2024 | Allow | 6 | 1 | 0 | Yes | No |
| 18409699 | TRANSAMINASE POLYPEPTIDES | January 2024 | June 2025 | Allow | 18 | 1 | 1 | Yes | No |
| 18404047 | CHITIN AND PROCESS FOR PRODUCING CHITIN AND/OR CHITOSAN BY THE ENZYMATIC AND CHEMICAL PATHWAY | January 2024 | February 2025 | Allow | 13 | 1 | 0 | Yes | No |
| 18389919 | ANTICOAGULANT FUSION PROTEINS AND USES THEREOF | December 2023 | January 2025 | Abandon | 13 | 0 | 1 | No | No |
| 18528794 | METHOD OF ETHANOL FERMENTATION WITH CELLULOSE AT HIGH-SOLIDS LOADING | December 2023 | April 2025 | Allow | 16 | 4 | 0 | Yes | No |
| 18339995 | SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF | June 2023 | January 2025 | Abandon | 19 | 0 | 1 | No | No |
| 18167707 | PROCESS OF EXTRACTING OIL FROM THIN STILLAGE | February 2023 | May 2025 | Allow | 27 | 2 | 0 | Yes | No |
| 18060517 | TRANSAMINASE POLYPEPTIDES | November 2022 | September 2023 | Allow | 10 | 1 | 1 | Yes | No |
| 18059949 | BIOCATALYSTS AND METHODS FOR HYDROXYLATION OF CHEMICAL COMPOUNDS | November 2022 | November 2024 | Allow | 23 | 1 | 1 | Yes | No |
| 17937111 | SELECTIVE SELF-ASSEMBLY BASED ARTIFICIAL METABOLON, PRODUCTION AND USE THEREOF | September 2022 | April 2025 | Abandon | 31 | 2 | 1 | No | No |
| 17931687 | ENGINEERED TYROSINE AMMONIA LYASE | September 2022 | August 2023 | Abandon | 11 | 1 | 0 | No | No |
| 17931677 | ENGINEERED TYROSINE AMMONIA LYASE | September 2022 | August 2023 | Abandon | 11 | 0 | 1 | No | No |
| 17899069 | Production of Steviol Glycosides in Recombinant Hosts | August 2022 | July 2024 | Allow | 22 | 1 | 1 | No | No |
| 17821297 | VARIANTS AND COMPOSITIONS COMPRISING VARIANTS WITH HIGH STABILITY IN PRESENCE OF A CHELATING AGENT | August 2022 | December 2023 | Allow | 16 | 1 | 1 | No | No |
| 17891385 | CANNABINOID AND TERPENE PRESERVATION IN BIOMASS USING WHOLE FERMENTATION BROTH | August 2022 | March 2024 | Allow | 19 | 2 | 1 | Yes | No |
| 17817783 | ENGINEERED TYROSINE AMMONIA LYASE | August 2022 | June 2023 | Abandon | 10 | 0 | 1 | No | No |
| 17817261 | Factor VIII Sequences | August 2022 | October 2024 | Abandon | 26 | 2 | 0 | Yes | No |
| 17772825 | STRAIN WITH IMPROVED AROMATIC AMINO ACID PRODUCTION CAPACITY BY GLSB GENE INACTIVATION | April 2022 | June 2025 | Abandon | 38 | 1 | 0 | No | No |
| 17703519 | METHOD FOR PRODUCING 2-METHYL-BUTYRIC ACID BY BACTERIAL FERMENTATION | March 2022 | April 2025 | Allow | 37 | 1 | 0 | Yes | No |
| 17698576 | ENGINEERED HEME-BINDING COMPOSITIONS AND USES THEREOF | March 2022 | November 2023 | Allow | 20 | 1 | 1 | No | No |
| 17694779 | Acid Phosphatase Mutants and Methods of Using the Same | March 2022 | April 2025 | Allow | 37 | 2 | 1 | Yes | No |
| 17687786 | METHOD OF GLYCATION OF A POLYPEPTIDE | March 2022 | September 2023 | Allow | 18 | 1 | 1 | Yes | No |
| 17636351 | BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS | February 2022 | March 2025 | Abandon | 37 | 1 | 0 | No | No |
| 17631985 | TUNING PROTEIN SOLUBILITY BY POLYMER SURFACE MODIFICATION | February 2022 | February 2025 | Abandon | 37 | 0 | 1 | No | No |
| 17583026 | MANUFACTURING OF GLYCOPROTEINS | January 2022 | November 2022 | Abandon | 10 | 0 | 0 | No | No |
| 17574406 | PRODUCTION OF CATALYTICALLY ACTIVE TYPE I SULFATASE | January 2022 | February 2024 | Abandon | 25 | 0 | 1 | No | No |
| 17625782 | ESTERASES AND METHODS OF USING THE SAME | January 2022 | March 2025 | Allow | 38 | 1 | 1 | Yes | No |
| 17569374 | Method of Inhibiting C5 Cleavage | January 2022 | December 2024 | Abandon | 35 | 2 | 1 | Yes | No |
| 17622619 | COMPOSITIONS AND METHODS FOR SYNTHESIS OF TERPENOIDS | December 2021 | January 2025 | Abandon | 37 | 0 | 1 | No | No |
| 17559782 | METHOD OF PURIFYING AND ISOLATING COLLAGENASE | December 2021 | June 2025 | Allow | 42 | 4 | 1 | No | No |
| 17619360 | METHOD FOR THE PRODUCTION OF ETHANOL FROM CORN FIBERS | December 2021 | January 2025 | Allow | 37 | 1 | 0 | Yes | No |
| 17550300 | ANIMAL FEED WITH ENGINEERED PHYTASES | December 2021 | August 2023 | Allow | 20 | 2 | 1 | Yes | No |
| 17548196 | STABILIZED THROMBIN | December 2021 | September 2024 | Allow | 33 | 5 | 0 | Yes | No |
| 17534399 | CELL CULTURE MEDIUM | November 2021 | July 2025 | Allow | 43 | 5 | 1 | Yes | No |
| 17610741 | SYNERGISTIC COMBINATIONS OF ARGININE-PRODUCING BACTERIA AND/OR AMMONIA-CONSUMING BACTERIA AND CHECKPOINT INHIBITORS AND METHODS OF USE THEREOF | November 2021 | November 2024 | Abandon | 36 | 0 | 1 | No | No |
| 17524466 | COMPOSITIONS COMPRISING NUCLEIC ACID MOLECULES AND METHODS OF TREATING ATPASE-MEDIATED DISEASES | November 2021 | March 2023 | Allow | 16 | 2 | 1 | Yes | No |
| 17519545 | CELL-TARGETED CYTOTOXIC CONSTRUCTS | November 2021 | November 2023 | Allow | 24 | 1 | 0 | Yes | No |
| 17509504 | Processes for Producing Ethanol | October 2021 | June 2023 | Allow | 20 | 1 | 1 | Yes | No |
| 17499599 | A METHOD FOR PRODUCING DIHYDROTENTOXIN | October 2021 | September 2023 | Allow | 23 | 1 | 1 | Yes | No |
| 17601673 | PRODUCTION OF CANNABINOIDS | October 2021 | January 2025 | Abandon | 39 | 2 | 1 | No | No |
| 17599153 | ENZYME NANOPARTICLES WITH METHANE OXIDATION ACTIVITY | September 2021 | November 2024 | Allow | 38 | 2 | 1 | Yes | No |
| 17470811 | POLYMER-FACTOR VIII MOIETY CONJUGATES | September 2021 | June 2024 | Abandon | 34 | 2 | 1 | No | No |
| 17458075 | COVALENT MODIFICATION OF BIOLOGICAL MACROMOLECULES | August 2021 | April 2023 | Abandon | 20 | 0 | 1 | No | No |
| 17411590 | ENZYME EXTRACTION METHODS | August 2021 | April 2025 | Allow | 44 | 4 | 1 | Yes | No |
| 17410262 | METHODS FOR PRODUCING ETHANOL | August 2021 | June 2023 | Allow | 21 | 1 | 0 | Yes | No |
| 17428344 | POLYNUCLEOTIDES | August 2021 | September 2024 | Allow | 37 | 4 | 1 | Yes | No |
| 17425288 | GENETICALLY ENGINEERED YEAST YARROWIA LIPOLYTICA AND METHODS FOR PRODUCING BIO-BASED GLYCOLIC ACID | July 2021 | February 2025 | Abandon | 43 | 1 | 1 | No | No |
| 17380714 | Method for Producing y-aminobutyric Acid (GABA) by Fermentation of Native Strain from Raw Material of Sayram Ketteki | July 2021 | February 2025 | Abandon | 43 | 3 | 1 | Yes | No |
| 17262184 | A METHOD OF TREATING PATHOGENIC BACTERIAL INFECTIOUS DISEASES | July 2021 | December 2024 | Allow | 47 | 2 | 0 | Yes | No |
| 17369830 | Compositions for Treating Pathological Calcification Conditions, and Methods Using Same | July 2021 | June 2024 | Allow | 35 | 1 | 1 | Yes | No |
| 17367212 | ENGINEERED PICHIA STRAIN AND A RECOMBINANT METHOD OF USING THE SAME FOR MAKING A COLLAGEN SPONGE | July 2021 | January 2025 | Allow | 42 | 2 | 0 | Yes | No |
| 17355962 | CMP-DEPENDENT SIALIDASE ACTIVITY | June 2021 | June 2023 | Allow | 23 | 1 | 0 | Yes | No |
| 17354628 | Method for Producing Basic L-Amino Acids or Salts Thereof By Fermentation of an Enterobacteriaceae Bacterium | June 2021 | January 2024 | Allow | 31 | 2 | 0 | Yes | No |
| 17312763 | BIOLOGICALS AND THEIR USE IN PLANTS | June 2021 | January 2025 | Abandon | 43 | 0 | 1 | No | No |
| 17340271 | Polypeptides having Alpha-Galactosidase Activity and Polynucleotides Encoding Same | June 2021 | May 2023 | Allow | 23 | 1 | 1 | Yes | No |
| 17338508 | Method of treating AML with PEGylated L-Asparaginase | June 2021 | June 2025 | Allow | 48 | 5 | 0 | Yes | No |
| 17299647 | BILIRUBIN OXIDASE ACTIVITY IMPROVING METHOD, AND BILIRUBIN OXIDASE PRODUCT | June 2021 | October 2024 | Abandon | 41 | 2 | 1 | No | No |
| 17293794 | RECOMBINANT VECTOR, HOST CELL AND PROCESS FOR PRODUCTION OF HUMAN SERUM ALBUMIN | May 2021 | April 2025 | Abandon | 48 | 2 | 0 | No | No |
| 17291821 | BIOCATALYTIC METHOD FOR PRODUCING 2H-HBO AND �-SUBSTITUTED ANALOGUES FROM LGO USING A CYCLOHEXANONE MONOOXYGENASE | May 2021 | December 2024 | Abandon | 43 | 3 | 1 | Yes | No |
| 17306386 | METHODS AND SYSTEMS FOR THE DETECTION AND REMOVAL OF PATHOGENS FROM BLOOD | May 2021 | June 2024 | Abandon | 37 | 4 | 1 | Yes | No |
| 17242181 | ENGINEERED TYROSINE AMMONIA LYASE | April 2021 | September 2022 | Abandon | 17 | 1 | 1 | Yes | No |
| 17288676 | Method of Precipitating Phytase | April 2021 | March 2023 | Abandon | 23 | 1 | 1 | No | No |
| 17240715 | POLYPEPTIDE TAG, HIGHLY SOLUBLE RECOMBINANT NITRILASE AND APPLICATION THEREOF IN SYNTHESIS OF PHARMACEUTICAL CHEMICALS | April 2021 | June 2023 | Allow | 26 | 3 | 1 | Yes | No |
| 17237618 | REPURPOSING INFLATABLE PACKAGING PILLOWS AS BIOREACTORS: CONVENIENT SYNTHESIS OF GLUCOSONE BY WHOLE-CELL CATALYSIS UNDER OXYGEN | April 2021 | July 2024 | Allow | 38 | 2 | 1 | Yes | No |
| 17229543 | SEMISYNTHETIC ROUTES TO ORGANIC COMPOUNDS | April 2021 | August 2024 | Allow | 40 | 2 | 1 | Yes | No |
| 17284837 | PROTEIN-POLYMER CONJUGATES AND METHODS FOR THEIR PREPARATION | April 2021 | April 2025 | Abandon | 48 | 4 | 1 | Yes | No |
| 17284186 | METHOD FOR RECYCLABLY USING AN ENZYME | April 2021 | August 2022 | Allow | 16 | 0 | 1 | No | No |
| 17224008 | TRANSAMINASE POLYPEPTIDES | April 2021 | August 2022 | Allow | 17 | 1 | 1 | Yes | No |
| 17221308 | Method for Producing Target Substance by Bacterial Fermentation | April 2021 | January 2024 | Allow | 34 | 2 | 0 | Yes | No |
| 17221613 | BIOCATALYSTS AND METHODS FOR HYDROXYLATION OF CHEMICAL COMPOUNDS | April 2021 | August 2022 | Allow | 17 | 1 | 1 | Yes | No |
| 17217912 | NUCLEIC ACID MOLECULES ENCODING NUCLEASE-ALBUMIN FUSION PROTEINS | March 2021 | July 2024 | Allow | 40 | 2 | 1 | Yes | No |
| 17205008 | CONTROLLABLE PROTEIN DEGRADATION VIA ENGINEERING DEGRADATION TAG VARIANTS IN CORYNEBACTERIUM HOST CELLS | March 2021 | May 2024 | Abandon | 38 | 2 | 1 | No | No |
| 17204244 | VARIANTS AND COMPOSITIONS COMPRISING VARIANTS WITH HIGH STABILITY IN PRESENCE OF A CHELATING AGENT | March 2021 | June 2022 | Allow | 15 | 2 | 0 | Yes | No |
| 17273140 | ENRICHING DHA IN GLYCERIDE FRACTIONS | March 2021 | July 2023 | Allow | 29 | 2 | 0 | Yes | No |
| 17267590 | SYSTEM AND METHOD FOR TREATING BIOMASS MATERIAL | February 2021 | December 2023 | Allow | 34 | 1 | 1 | Yes | No |
| 17265277 | Protein C-Factor VII Chimeras | February 2021 | July 2022 | Allow | 17 | 2 | 1 | Yes | No |
| 17264758 | BIOSYNTHETIC PLATFORM FOR THE PRODUCTION OF CANNABINOIDS AND OTHER PRENYLATED COMPOUNDS | January 2021 | June 2022 | Allow | 16 | 1 | 1 | Yes | No |
| 17264748 | Non-Specific Nucleases from the Genus Pseudomonas for Use in Facilitating Flow of Cells Through a Microfluidic Channel | January 2021 | January 2024 | Allow | 36 | 4 | 1 | Yes | No |
| 17157880 | PROGRAMMABLE PROTEIN CIRCUITS IN LIVING CELLS | January 2021 | December 2023 | Allow | 35 | 1 | 1 | Yes | No |
| 17150900 | MICROORGANISM FOR FERMENTATIVE PRODUCTION OF 2-PHENYLETHANOL FROM GASEOUS SUBSTRATES | January 2021 | October 2024 | Allow | 45 | 3 | 1 | Yes | No |
| 17148834 | ENGINEERED TYROSINE AMMONIA LYASE | January 2021 | April 2022 | Allow | 15 | 2 | 1 | Yes | No |
| 17259616 | IN VIVO POST-TRANSLATIONAL PROCESSING OF TARGET PROTEIN BY FURIN IN PLANTS: ENGINEERING, EXPRESSION AND PRODUCTION OF FUNCTIONAL ACTIVE HUMAN FURIN IN N. BENTHAMIANA PLANTS | January 2021 | July 2023 | Abandon | 30 | 1 | 1 | No | No |
| 17135163 | ENZYMES OF LUCIFERIN BIOSYNTHESIS AND USE THEREOF | December 2020 | December 2023 | Abandon | 35 | 1 | 1 | Yes | No |
| 17132117 | Methods and Compositions for Oral Administration of Proteins | December 2020 | January 2023 | Allow | 25 | 1 | 1 | Yes | No |
| 17127570 | METHOD OF PURIFYING CANNABINOIDS FROM YEAST FERMENTATION BROTH | December 2020 | March 2022 | Abandon | 15 | 1 | 0 | No | No |
| 17252454 | HUMAN CGAS-DNA COMPLEX AND ENCODED PROTEIN | December 2020 | July 2024 | Allow | 43 | 4 | 1 | Yes | No |
| 17120160 | CONSTRUCTION OF MUCOR CIRCINELLOIDES CELL FACTORY FOR PRODUCING STEARIDONIC ACID AND FERMENTATION TECHNOLOGY THEREOF | December 2020 | April 2022 | Allow | 16 | 2 | 1 | Yes | No |
| 17108020 | POLYPEPTIDES HAVING LIPASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME | December 2020 | May 2022 | Allow | 18 | 2 | 1 | Yes | No |
| 17059999 | OVER-EXPRESSION OF TRANSCRIPTIONAL ACTIVATOR/REPRESSOR GIS1 IN YEAST FOR INCREASED ETHANOL PRODUCTION | November 2020 | October 2022 | Abandon | 22 | 1 | 1 | No | No |
| 17059979 | PROCESS FOR PRODUCING PHYCOCYANIN-RICH BIOMASS VIA URA CULTURING | November 2020 | September 2022 | Allow | 22 | 2 | 0 | Yes | No |
| 17102361 | MANGANESE SUPPLEMENTATION FOR CONTROL OF GLYCOSYLATION IN MAMMALIAN CELL CULTURE PROCESS | November 2020 | February 2023 | Abandon | 27 | 1 | 1 | No | No |
| 17054526 | MANNANASE PMAN5A MUTANT HAVING IMPROVED HEAT RESISTANCE, GENE THEREOF, AND APPLICATION | November 2020 | April 2022 | Allow | 17 | 1 | 1 | Yes | No |
| 17085135 | OILS, LIPIDS AND FATTY ACIDS PRODUCED IN TRANSGENIC BRASSICA PLANT | October 2020 | February 2022 | Abandon | 16 | 2 | 0 | No | No |
| 17051514 | TRANSFORMANT OF CORYNEFORM BACTERIUM AND PRODUCTION METHOD FOR USEFUL COMPOUND USING SAME | October 2020 | March 2022 | Allow | 17 | 2 | 0 | Yes | No |
| 17050549 | PROCESS AND SYSTEM FOR MICROBIAL FERMENTATION | October 2020 | September 2024 | Abandon | 47 | 1 | 1 | No | No |
| 17078613 | ANTIMICROBIAL PEPTIDE ID13, PREPARATION METHOD AND USE THEREOF | October 2020 | August 2023 | Allow | 34 | 2 | 1 | Yes | No |
| 17046993 | Method for Manufacturing Bacterium-Produced Cellulose Carbon | October 2020 | July 2022 | Allow | 21 | 2 | 0 | Yes | No |
| 17068262 | MICROORGANISMS WITH ENHANCED CARBON MONOXIDE AVAILABILITY AND USE THEREOF | October 2020 | September 2022 | Allow | 23 | 1 | 1 | Yes | No |
| 17045149 | PAENIBACILLUS PABULI-DERIVED ENZYME CAPABLE OF PRODUCING GALACTO-OLIGOSACCHARIDE, AND METHOD FOR PRODUCING GALACTO-OLIGOSACCHARIDE | October 2020 | February 2024 | Allow | 47 | 4 | 1 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner ROBINSON, HOPE A.
With a 37.5% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 27.9% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner ROBINSON, HOPE A works in Art Unit 1652 and has examined 1,199 patent applications in our dataset. With an allowance rate of 62.8%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 33 months.
Examiner ROBINSON, HOPE A's allowance rate of 62.8% places them in the 16% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by ROBINSON, HOPE A receive 2.22 office actions before reaching final disposition. This places the examiner in the 75% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by ROBINSON, HOPE A is 33 months. This places the examiner in the 26% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +50.7% benefit to allowance rate for applications examined by ROBINSON, HOPE A. This interview benefit is in the 94% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 22.7% of applications are subsequently allowed. This success rate is in the 20% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 46.8% of cases where such amendments are filed. This entry rate is in the 65% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 83.3% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 63% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 78.1% of appeals filed. This is in the 66% percentile among all examiners. Of these withdrawals, 78.9% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 72.8% are granted (fully or in part). This grant rate is in the 89% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 10.3% of allowed cases (in the 96% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 36.9% of allowed cases (in the 96% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.